Recent publications published by researchers at the MRC WIMM.
Idiopathic pulmonary fibrosis in the UK: findings from the British Thoracic Society UK Idiopathic Pulmonary Fibrosis Registry
Fahim A. et al, (2025), BMJ Open Respiratory Research, 12, e002773 - e002773
Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.
Tyrer F. et al, (2024), Diabetes Obes Metab
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.
Liew F. et al, (2024), Nat Immunol, 25, 607 - 621
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.
Devine K. et al, (2024), Clin Endocrinol (Oxf), 100, 317 - 327
Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis.
Weeratunga P. et al, (2024), J Clin Invest, 134
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Taquet M. et al, (2024), Brain Commun, 6
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
(2023), International journal of epidemiology, 53
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.
Weeratunga P. et al, (2023), Nat Commun, 14
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Taquet M. et al, (2023), Nat Med, 29, 2498 - 2508
Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study.
Astley JR. et al, (2023), J Magn Reson Imaging, 58, 1030 - 1044
Neutrophil levels correlate with quantitative extent and progression of fibrosis in IPF: results of a single-centre cohort study.
Achaiah A. et al, (2023), BMJ Open Respir Res, 10
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2.
Wilkinson T. et al, (2023), ERJ Open Res, 9
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Jackson C. et al, (2023), Lancet Respir Med, 11, 673 - 684
Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis.
Dawson C. et al, (2023), BMJ Open Respir Res, 10
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls.
Zheng B. et al, (2023), Lancet Reg Health Eur, 29
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study.
Stewart I. et al, (2023), Am J Respir Crit Care Med, 207, 693 - 703
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
McAuley HJC. et al, (2023), EClinicalMedicine, 57